Publication | Closed Access
<i>N</i> 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
12
Citations
56
References
2023
Year
Increased FZR1 translation induced by m6A modification engenders a gemcitabine-resistant phenotype by inducing a quiescent state and confers a targetable vulnerability to improve treatment response in PDAC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1